Contact : info@zylera.com
Latest Press Release
Company Hires Seasoned Executive In Parallel With New Product Launches
Research Triangle Park, NC, November 15, 2011 — Zylera Pharmaceuticals, LLC, a specialty pharmaceutical company that develops, acquires and commercializes prescription pharmaceutical products and dietary supplements and markets those products in the U.S. is pleased to announce the appointment of Matthew V. Phillips as Chief Operating Officer. Prior to joining Zylera Matt was Executive Director…
read more...
BioTech news Sales & Marketing- Vascular Magnetics Raises $7 Million in Series A Financing to Advance Magnetically Targeted Drug Delivery System for Peripheral Artery Disease
- Integrated Diagnostics(R) Secures $10 Million Third Tranche of Series A Financing
- Teleflex Signs Regional Anesthesia Agreement with German Asklepios Hospital Group for ambIT(R) PCA Pump
- US Patent Office Rejects All Claims in Second MonoSol Patent
Sales & Marketing- Vascular Magnetics Raises $7 Million in Series A Financing to Advance Magnetically Targeted Drug Delivery System for Peripheral Artery Disease
- Integrated Diagnostics(R) Secures $10 Million Third Tranche of Series A Financing
- Teleflex Signs Regional Anesthesia Agreement with German Asklepios Hospital Group for ambIT(R) PCA Pump
- US Patent Office Rejects All Claims in Second MonoSol Patent